Woodline Partners LP Revolution Medicines, Inc. Transaction History
Woodline Partners LP
- $9.97 Billion
- Q2 2024
A detailed history of Woodline Partners LP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 3,290,791 shares of RVMD stock, worth $144 Million. This represents 1.28% of its overall portfolio holdings.
Number of Shares
3,290,791
Previous 3,797,148
13.34%
Holding current value
$144 Million
Previous $122 Million
4.36%
% of portfolio
1.28%
Previous 1.17%
Shares
18 transactions
Others Institutions Holding RVMD
# of Institutions
231Shares Held
161MCall Options Held
251KPut Options Held
133K-
Vanguard Group Inc Valley Forge, PA14.4MShares$631 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA13.7MShares$599 Million0.1% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$588 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA9.76MShares$428 Million1.83% of portfolio
-
Baker Bros. Advisors LP New York, NY7.57MShares$332 Million3.9% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.85B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...